North Eastern Carrying Corporation Fund Raise of ₹7.5 Cr

North Eastern Carrying Corporation Other Announcement

North Eastern Carrying Corporation filed its Reg 32 statement for the rights issue, covering the quarter to September 30, 2026. It reports a deviation from original objects, with funds utilised so far shown as nil.

North Eastern Carrying Corporation Management Change

North Eastern Carrying changed Utkarsh Jain's designation from Whole-time Director to Non-Executive Non-Independent Director, effective 24 October 2026. The change follows his request citing external commitments.

North Eastern Carrying Corporation Q2 FY27 Results: Net Profit ₹2.2 Cr, Up 22.2% YoY

North Eastern Carrying Corporation Ltd reported revenue from operations of ₹76.3 Cr (+7.9% YoY) and net profit of ₹2.2 Cr (+22.2% YoY) for Q2 FY27.

Key figure

Net profit ₹2.2 Cr · +22.2% YoY

North Eastern Carrying Corporation Board Meeting Date

North Eastern Carrying Corporation will hold a board meeting on October 24, 2026, to consider and approve unaudited financial results for the half year ended September 2026.

North Eastern Carrying Corporation Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure of share ownership structure.

North Eastern Carrying Corporation Annual General Meeting

NECCLTD filed the minutes of its 41st AGM held on 10 September 2026. It adopted FY26 results, re-appointed Utkarsh Jain as director, and Nemani Garg Agarwal as auditors.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.